With the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.
David Kessler said acting leader Kyle Diamantas has what it takes to bring stability
Former FDA commissioner David Kessler spoke at the Breakthrough Summit West in San Francisco on Tuesday.Jack Simpson for STAT
By Anil OzaMay 19, 2026
General Assignment Reporter
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16.
Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the…
They called for stability and predictability at the agency at Axios' Future of Health summit.
The agency may not have permanent leadership until after the midterms, says one expert
The agency is looking for way more than just a new commissioner.
With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across…
How the ouster of key officials at the FDA has created anxiety and uncertainty for the developers of rare disease drugs.
Biopharma industry endorses Pazdur for FDA commissioner role - Pharmaceutical Technology
